Embree Financial Group’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-90,906
Closed -$68.2K – 303
2026
Q2
$68.2K Sell
90,906
-27,272
-23% -$22.3K 0.01% 283
2026
Q1
$73.3K Buy
118,178
+6,860
+6% +$5.96K 0.01% 261
2025
Q4
$131K Buy
111,318
+97,318
+695% +$123K 0.02% 233
2025
Q3
$20.9K Hold
14,000
– – ﹤0.01% 232
2025
Q2
$27.2K Hold
14,000
– – ﹤0.01% 214
2025
Q1
$17.1K Buy
14,000
+1,500
+12% +$3.69K ﹤0.01% 201
2024
Q4
$37.8K Buy
12,500
+2,500
+25% +$7.03K 0.01% 194
2024
Q3
$25.3K Buy
+10,000
New +$35.6K ﹤0.01% 195

Other funds holding TELA

Embree Financial Group's TELA Position: Q3 2026 in Review

Embree Financial Group sold out of TELA Bio (TELA) in Q3 2026, closing a stake of 90,906 shares — an estimated $68.2K sold.

Embree Financial Group first reported a position in TELA in Q3 2024 and held it in 8 quarters. The position peaked at $131K in Q4 2025. 48 funds tracked by Wall St. Rank hold TELA as of Q3 2026.

  • Embree Financial Group reported no remaining TELA Bio position as of Q3 2026 after selling out during the quarter.
  • Embree Financial Group sold 90,906 TELA Bio shares in Q3 2026, an estimated $68.2K.
  • Embree Financial Group first reported a position in TELA Bio in Q3 2024 and held it in 8 quarters.
  • Embree Financial Group's TELA Bio position peaked at $131K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held TELA Bio as of Q3 2026.

Based on Embree Financial Group's 13F filing for Q3 2026, filed 22 Oct 2026.